首页> 外文期刊>Open Journal of Internal Medicine >Seronegative Myasthenia Gravis and a Biermer’s Anemia: A Rare Association
【24h】

Seronegative Myasthenia Gravis and a Biermer’s Anemia: A Rare Association

机译:血清腺肌肌肌瘤和生物商的贫血:一种罕见的协会

获取原文
           

摘要

We report a rare association of seronegative myasthenia gravis and a Biermer’s anemia (or pernicious anemia). A Senegalese patient of 31 years has been followed for a vitamin B12 deficiency anemia, 12 months before his hospitalization in our department. She has been admitted for an intense and invalidating fatigability in spite of the correction of anemia, associated to a right ptosis. This clinical picture has electively been improved to the prostigmine test. The electromyography had revealed a compatible decrement with a diagnosis of myasthenia. The positivity of the antibodies anti gastric parietal cells and the twice negativity of the antibody against acetylcholine receptor (AChR) and muscle-specific kinase (MuSK) had permitted to deduct a diagnosis of seronegative myasthenia and Biermer’s anemia. The evolution was favorable under substitutive B12 vitamin therapy associated to corticotherapy and azathioprine. We insist on the research and the early treatment of a myasthenia, in a context of Biermer’s anemia, before suggestive clinical signs in spite of the negativity of the anti-Rach antibodies and anti-Musk.
机译:我们举行罕见的血清腺肌肌肌瘤和生物商的贫血(或可生性贫血)协会。维生素B12缺乏症患者的塞内加尔人类患者,在我们部门住院前12个月。尽管贫血纠正,她已被致力于激烈和无效的疲劳,但与右侧病相关联。该临床图选择于普尔氏肾冬季试验。肌电学术揭示了兼容衰落的衰落。抗体抗胃壁细胞的阳性和抗体对乙酰胆碱受体(ACHR)和肌肉特异性激酶(麝香)的两倍允许扣除血清肌病和Biermer的贫血的诊断。在与皮质疗法和氮嘌呤相关的替代B12维生素治疗下,进化是有利的。我们坚持研究和早期治疗肌炎,在生物商的贫血的背景下,尽管抗Rach抗体和抗麝香的消极性,但仍然存在暗示临床症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号